List of Contents

Weight Loss Supplement Market Size, Share, and Trends 2024 to 2034

The global weight loss supplement market size accounted for USD 33.18 billion in 2024, grew to USD 37.89 billion in 2025 and is estimated to hit around USD 125.75 billion by 2034, representing a CAGR of 14.25% between 2024 and 2034. The North America weight loss supplement market size is evaluated at USD 12.28 billion in 2024 and is expected to grow at a CAGR of 14.39% during the forecast year.

  • Last Updated : November 2024
  • Report Code : 5272
  • Category : Food and Beverages

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Weight Loss Supplement Market 

5.1. COVID-19 Landscape: Weight Loss Supplement Industry Impact

5.2. COVID-19  Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Weight Loss Supplement Market, By Type

8.1. Weight Loss Supplement Market Revenue and Volume Forecast, by Type, 2024-2034

8.1.1. Liquid

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Powder

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Softgels

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Pills

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Weight Loss Supplement Market, By Ingredient

9.1. Weight Loss Supplement Market Revenue and Volume Forecast, by Ingredient, 2024-2034

9.1.1. Vitamins and Minerals

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Amino Acids

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Natural Extracts/ Botanicals

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Weight Loss Supplement Market, By End-use

10.1. Weight Loss Supplement Market Revenue and Volume Forecast, by End-use, 2024-2034

10.1.1. Under 18 Years

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. 18 To 40 Years

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. 41 To 50 Years

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Above 50 Years

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Weight Loss Supplement Market, By Distribution Channel 

11.1. Weight Loss Supplement Market Revenue and Volume Forecast, by Distribution Channel, 2024-2034

11.1.1. Offline Channel

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Online Channel

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Weight Loss Supplement Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, by Ingredient (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

Chapter 13. Company Profiles

13.1. Glanbia PLC

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. GlaxoSmithKline PLC

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Herbalife Nutrition Ltd.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Nestle

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Amway Corp.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Ajinomoto Co. Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. NutriSport Pharmacal, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. GNC Holdings, LLC

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. GNC Holdings, LLC

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us